Sign in
Not yet recruitingNo phase

RF GP Ablation Added to PEF PVI for Paroxysmal AF

Key facts

Who runs it
Institute for Clinical and Experimental Medicine
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
250 people, planned
Starts
1 Apr 2027
Expected to end
1 Apr 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • pulmonary vein isolation and roof line ablation
  • GP ablation
Record updated
17 November 2026

Who can take part

Age
30 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Patients with drug-resistant symptomatic paroxysmal AF meeting all the following criteria:; Paroxysmal AF that terminates spontaneously or with intervention within 7 days of onset; Failed AAD treatment, defined as ineffective, intolerant or inappropriate ≥1 Class I-IV AAD
  • Patients who are ≥30 and ≤65 years of age on the day of enrolment
  • Patients who are willing and capable of:; Providing informed consent to undergo study procedures AND; Participating in all examinations, follow-up visits, and tests associated with this clinical study
  • Effective contraception for women of childbearing potential
  • Effective oral anticoagulation for >3 weeks before the planned ablation procedure

Who cannot take part

  • Any prior atrial endocardial or epicardial ablation procedure, including cavotricuspid isthmus (CTI) ablation or right-sided AT
  • Any prior atrial surgery
  • AF secondary to electrolyte imbalance, thyroid disease, alcohol, or other reversible / non-cardiac causes
  • Autonomic dysfunction, e.g., cardiac autonomic neuropathy due to diabetes mellitus
  • Left ventricular ejection fraction <40%
  • Persistent, long-standing persistent, or permanent AF
  • Left atrial (LA) anteroposterior diameter ≥50 mm (by transthoracic echocardiography)
  • Intra-atrial septal patch or interatrial shunt
  • General contraindications of catheter ablation
  • LA appendage closure, device, or occlusion, past or anticipated

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 30 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will investigate whether adjunctive RF GP ablation, when added to PF PVI, improves freedom from AF or atrial tachycardia (AT). By directly addressing the potential limitation of autonomic modulation associated with PF ablation alone, this study will provide mechanistic and clinically relevant insights into the role of parasympathetic modulation of the heart in preventing AF recurrence.

Read full original descriptionShow less

The results are expected to yield novel, clinically meaningful evidence that may help refine and optimize catheter ablation workflows, particularly in the era of non-thermal energy sources.

The 2 groups in the trial

  • RF GP + PEF PVITreatment being tested

    Radiofrequency ablation of ganglionated plexi added to pulmonary vein isolation and roof line ablation using pulsed electric field

    Treatment: pulmonary vein isolation and roof line ablation and GP ablation

  • PEF PVIExisting treatment, for comparison

    Pulmonary vein isolation and roof line ablation using pulsed electric field energy

    Treatment: pulmonary vein isolation and roof line ablation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
RadiofrEquency Ablation of Ganglionated Plexi Added to The Pulsed ElecTric Field Pulmonary Vein Isolation for PAroxysmal Atrial Fibrillation (REGATTA-AF Study)
Criteria questions
Built from NCT07943013, who can take part
Record updated
17 November 2026